Filing Flows › Johnson & Johnson (JNJ) › R&D spending
Johnson & Johnson (JNJ) R&D spending by quarter
Johnson & Johnson's R&D spending was $4.7B in Q3 2026 (third quarter 2026), +27% from Q2 2026. Over the last 5 quarters it ranged from $3.5B (Q2 2025) to $4.7B (Q3 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $4.7B | +27% | — |
| Q2 2026 | $3.7B | +4% | +4% |
| Q1 2026 | $3.5B | -17% | — |
| Q4 2025 | $4.3B | +21% | — |
| Q2 2025 | $3.5B | — | — |
Q3 2026 at a glance
Johnson & Johnson, Q3 2026: revenue $25.4B (+6% year over year), operating margin 0.1%, net earnings $210M, operating cash flow $7.7B. The chart follows the revenue to costs, profit and cash.
Questions
What is Johnson & Johnson's R&D spending?
Johnson & Johnson's R&D spending was $4.7B in Q3 2026 (third quarter 2026), +27% from Q2 2026.
How has Johnson & Johnson's R&D spending changed?
Over the last 5 quarters it ranged from $3.5B (Q2 2025) to $4.7B (Q3 2026).